Literature DB >> 8456047

Nicotine dependence. Diagnosis and treatment.

J Cocores1.   

Abstract

Psychiatrists must become more involved in the engagement and treatment of nicotine-dependent patients in their clinical practice because it is the number one killer in the DSM-III-R. There is no single treatment that will fit all psychiatric patients. Instead, a carefully tailored treatment plan is generated using the seven tier system to fit each patient and their psychosocial profile. Psychiatrists have the medical, social, and psychological training needed to manage nicotine-dependent patients. Although further research is needed, psychiatrists should no longer ignore their responsibility to treat nicotine dependence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8456047

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  11 in total

1.  Negative affect as a mediator of the relationship between vigorous-intensity exercise and smoking.

Authors:  Candyce D Tart; Teresa M Leyro; Ashley Richter; Michael J Zvolensky; David Rosenfield; Jasper A J Smits
Journal:  Addict Behav       Date:  2010-02-01       Impact factor: 3.913

2.  Relations between anxiety sensitivity, distress tolerance, and fear reactivity to bodily sensations to coping and conformity marijuana use motives among young adult marijuana users.

Authors:  Michael J Zvolensky; Erin C Marshall; Kirsten Johnson; Julianna Hogan; Amit Bernstein; Marcel O Bonn-Miller
Journal:  Exp Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.157

3.  The roles of sex, anxious reactivity to bodily arousal, and anxiety sensitivity in coping motives for cigarette smoking among adolescents.

Authors:  Sarah A Bilsky; Matthew T Feldner; Ashley A Knapp; Sasha M Rojas; Ellen W Leen-Feldner
Journal:  Exp Clin Psychopharmacol       Date:  2016-04-07       Impact factor: 3.157

4.  Main and interactive effects of emotion dysregulation and breath-holding duration in relation to panic-relevant fear and expectancies about anxiety-related sensations among adult daily smokers.

Authors:  Charles P Brandt; Kirsten A Johnson; Norman B Schmidt; Michael J Zvolensky
Journal:  J Anxiety Disord       Date:  2011-11-06

5.  Posttraumatic stress symptoms and cigarette deprivation in the prediction of anxious responding among trauma-exposed smokers: a laboratory test.

Authors:  Anka A Vujanovic; Erin C Marshall-Berenz; Jean C Beckham; Amit Bernstein; Michael J Zvolensky
Journal:  Nicotine Tob Res       Date:  2010-09-16       Impact factor: 4.244

6.  Panic attack history and anxiety sensitivity in relation to cognitive-based smoking processes among treatment-seeking daily smokers.

Authors:  Kirsten A Johnson; Samantha G Farris; Norman B Schmidt; Jasper A J Smits; Michael J Zvolensky
Journal:  Nicotine Tob Res       Date:  2012-04-27       Impact factor: 4.244

7.  Anxiety sensitivity and cognitive-based smoking processes: testing the mediating role of emotion dysregulation among treatment-seeking daily smokers.

Authors:  Kirsten A Johnson; Samantha G Farris; Norman B Schmidt; Michael J Zvolensky
Journal:  J Addict Dis       Date:  2012

8.  Anxious arousal and anhedonic depression symptoms and the frequency of current marijuana use: testing the mediating role of marijuana-use coping motives among active users.

Authors:  Kirsten A Johnson; Marcel O Bonn-Miller; Teresa M Leyro; Michael J Zvolensky
Journal:  J Stud Alcohol Drugs       Date:  2009-07       Impact factor: 2.582

9.  Distress Tolerance Scale: A Confirmatory Factor Analysis Among Daily Cigarette Smokers.

Authors:  Teresa M Leyro; Amit Bernstein; Anka A Vujanovic; Alison C McLeish; Michael J Zvolensky
Journal:  J Psychopathol Behav Assess       Date:  2011-03

10.  Anxiety sensitivity and panic reactivity to bodily sensations: relation to quit-day (acute) nicotine withdrawal symptom severity among daily smokers making a self-guided quit attempt.

Authors:  Erin C Marshall; Kirsten Johnson; Jenna Bergman; Laura E Gibson; Michael J Zvolensky
Journal:  Exp Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.